SynthesisRheumatology (Oxford, England)2026
The thrombotic burden of high-risk immune thrombocytopenia patients receiving second-line treatments: a systematic review.
Elisa Tarasconi et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.